Risk Factors for Tigecycline‐Associated Hepatotoxicity in Patients in the Intensive Care Units of 2 Tertiary Hospitals: A Retrospective Study-Reference-Cited by-同舟云学术

Risk Factors for Tigecycline‐Associated Hepatotoxicity in Patients in the Intensive Care Units of 2 Tertiary Hospitals: A Retrospective Study

Published:2022-07-05 Issue:11 Volume:62 Page:1426-1434
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Jiang Tingting¹,Huang Xuhui¹,Liu Qinghua²,Feng Hangwei³,Huang Yiting¹,Lin Jian³,Huang Long³,Chen Shufang¹,Zhuang Yingfeng³,Weng Cuilian³

Affiliation:

1. Department of Pharmacy Shengli Clinical Medical College of Fujian Medical University Fujian Provincial Hospital South Branch Fujian Provincial Jinshan Hospital Fuzhou Fujian Province China

2. Department of Otorhinolaryngology Shengli Clinical Medical College of Fujian Medical University Fujian Provincial Hospital Fuzhou Fujian Province China

3. Department of Critical Care Medicine Shengli Clinical Medical College of Fujian Medical University Fujian Provincial Hospital South Branch Fujian Provincial Jinshan Hospital Fuzhou Fujian Province China

Funder

Natural Science Foundation of Fujian Province

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.2099

Reference27 articles.

1. Tigecycline: a critical safety review

2. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review;Yaghoubi S;Eur J Clin Microbiol Infect Dis,2021

3. Wyeth seeks global regulatory approval of Tygacil (tigecycline) for injection.https://www.drugs.com/nda/tygacil_041215.html. Accessed November 10 2021.

4. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes

5. FDA Drug Safety Communication. Increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections.http://www.fda.gov/Drugs/DrugSafety/ucm224370.htm. Published2017 Accessed November 15 2021.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic-Associated Drug-Induced Liver Injury in Critically Ill Children: A Prospective Observational Study;Safety and Risk of Pharmacotherapy;2023-12-04

2. A retrospective analysis of the incidence of severe adverse events among recipients of chiropractic spinal manipulative therapy;Scientific Reports;2023-01-23